
Please try another search
Jiangsu Hengrui Medicine Co., Ltd., a pharmaceutical company, researches, develops, manufactures, and commercializes drugs in China and internationally. The company develops antineoplastic drugs; surgery medications; medicines for oncology, autoimmune diseases, pain management, metabolic diseases, cardiovascular diseases, infectious diseases, respiratory system diseases, hematological diseases, neurological diseases, and ophthalmology, etc.; analgesia and anesthesia products; and contrast agents. It is also involved in technical consulting; training; investment advisory; technology development; project; information; and investing services, as well as the import and export of pharmaceutical products. The company has license agreement with GSK plc to develop up to 12 innovative medicines in respiratory, immunology and inflammation, and oncology areas. Jiangsu Hengrui Medicine Co., Ltd. was founded in 1970 and is headquartered in Lianyungang City, China.
Name | Age | Since | Title |
---|---|---|---|
Kai Hong Yuan | 60 | 2023 | Chairman of the Supervisory Board |
Piao Yang Sun | 67 | 1997 | Executive Chairman of the Board |
Jin Yun Sun | 53 | 2023 | Independent Non-Executive Director |
Yu Xu | 32 | 2022 | Employee Supervisor |
Kyan Mervyn Chow | 52 | 2025 | Independent Non-Executive Director |
Qingsheng Zeng | 50 | 2023 | Independent Non-Executive Director |
Congzhao Guo | 52 | 2020 | Non-Executive Director |
Guo Qiang Xiong | 49 | 2010 | Supervisor |
Ningjun Jiang | 64 | 2023 | Executive VP, Chief Strategy Officer & Executive Director |
Jiahong Dong | 64 | 2021 | Independent Non-Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review